Request A Quote
GxPortal (for Providers)
Search for:
Products & Tests
Clinical Genetic Testing
GxVISION Carrier Screening
EnVISION® Non-Invasive Prenatal Screening
GxVISION Hereditary Cancer Risk Assessment
GxVISION Congenital Hearing Loss
GBinsight Familial Hypercholesterolemia
GBinsight Familial Hyperlipidemia
Clinical Exome Sequencing
Genomic Medicine
Otogenetics COVID-19 PCR Testing
COVID-19 PCR Testing
COVID-19 IgM/IgG Antibody Testing
Instructions for Specimen Collection and Shipment
Reference Result Range for COVID-19 Antibody Testing
Research and Clinical Trials
Whole Exome Sequencing
RNA Sequencing
Disease Gene Panels
Clinical Trials
Biomarkers Identification
Nutritional Genomics
Additional Next Generation Sequencing Products & Services
Resources
Clinical Genetic Testing
Specimen Collection Video
Genetic Counseling
What do the results of genetic testing mean?
Notice of Privacy Practices
Research and Clinical Trials
Publications
White Papers
Sample Requirements
Domestic Shipping
International Shipping
Patient Info
Genetic Counseling
Hereditary Cancer Risk Assessment
EnVISION® Non-Invasive Prenatal Screening
Carrier Screening
Hearing Loss & Newborn Screening
Cardiomyopathy
Clinical Exome Sequencing & Rare Hereditary Diseases
Notice of Privacy Practices
Support
About
547424802
Previous
Recent Posts
Computation Biology Modeling (CBM) Based on NGS Data Provided By Otogenetics for Personalized Treatment of Non-responding Cancer Patients
Somatic activating mutations in MAP2K1 cause melorheostosis
Otogenetics helps clinicians in discovery of a novel autosomal dominant hearing loss mutation
